Press Releases

and/or
565 News Releases found
Left to right: Eileen M. O'Reilly, MD, Christine A. Iacobuzio-Donahue, MD, PhD
Memorial Sloan Kettering Cancer Center Receives NCI SPORE Grant to Improve Outcomes for Patients with Pancreatic Cancer

Memorial Sloan Kettering Cancer Center (MSK) today announced that it has been awarded a Specialized Programs of Research Excellence (SPORE) grant for pancreatic research by the National Cancer Institute (NCI).
Sloan Kettering Institute’s Alexander Gitlin
Sloan Kettering Institute’s Alexander Gitlin Honored with Prestigious NIH Director’s Early Independence Award

Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award.
MSK Awards & Appointments September 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
CAR T-Cell Therapy Proves Effective in First Trial in Patients with Resistant Multiple Myeloma

A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute, and Roswell Park Comprehensive Cancer Center report in a new study.
Memorial Sloan Kettering Cancer Center Creates Innovative Telemedicine Platform to Provide Patients Greater Access to Care

Memorial Sloan Kettering Cancer Center (MSK) is marking a year since the launch of MSK Telemedicine – an online solution for remote care that has been ...
Francesca Gany
MSK Receives Grant to Help Increase Cancer Outcomes Equity in New York Region

The funding will support patient navigation, essential needs, telemedicine, and psychosocial support services, including language translation and interpretation.
Selwyn M. Vickers
Dr. Selwyn M. Vickers Joins Memorial Sloan Kettering Cancer Center as President and CEO

Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has joined the institution as President and Chief Executive Officer.
Jonathan E. Rosenberg, MD
ESMO 2022: Research Reveals Promising New Combination Treatment for Bladder Cancer Patients

Nearly two thirds of patients who were treated with the combination enfortumab vedotin plus pembrolizumab saw their tumors shrink.
Memorial Sloan Kettering Cancer Center Announces Strategic Real Estate Investments

Memorial Sloan Kettering Cancer Center (MSK) today announced details of strategic real estate investments that will support the world class cancer center into the future. In March 2022, MSK announced plans to build a new, state-of-the-art cancer care Pavilion on the Upper East Side campus to address the evolving cancer care needs of patients over the next century.
MSK Awards & Appointments August 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments for August 2022.